| __timestamp | Arrowhead Pharmaceuticals, Inc. | AstraZeneca PLC |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 5579000000 |
| Thursday, January 1, 2015 | 57410147 | 5997000000 |
| Friday, January 1, 2016 | 41454452 | 5890000000 |
| Sunday, January 1, 2017 | 31690298 | 5757000000 |
| Monday, January 1, 2018 | 52968505 | 5932000000 |
| Tuesday, January 1, 2019 | 81048686 | 5958000000 |
| Wednesday, January 1, 2020 | 128874979 | 5991000000 |
| Friday, January 1, 2021 | 206342000 | 9736000000 |
| Saturday, January 1, 2022 | 297307000 | 9762000000 |
| Sunday, January 1, 2023 | 353188000 | 10935000000 |
| Monday, January 1, 2024 | 505870000 | 13583000000 |
Infusing magic into the data realm
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc. are two prominent players in this field, each with distinct strategies. Over the past decade, AstraZeneca has consistently invested heavily in R&D, with expenditures peaking at approximately $10.9 billion in 2023, marking a 96% increase from 2014. In contrast, Arrowhead Pharmaceuticals, while smaller in scale, has shown a remarkable growth trajectory, with R&D spending surging by over 2,000% from 2014 to 2024. This stark difference highlights AstraZeneca's established presence and Arrowhead's aggressive growth strategy. The data for 2024 is incomplete for AstraZeneca, but the trend suggests a continued focus on innovation. These insights underscore the dynamic nature of the pharmaceutical industry and the varied approaches companies take to drive progress.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Perrigo Company plc vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Arrowhead Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.